oprozomib (Compound)

Synonyms:Oprozomib, 935888-69-0, ONX-0912, ONX 0912, Oprozomib (ONX-0912), PR-047, Oprozomib (ONX 0912), UNII-MZ37792Y8J, PR 047, MZ37792Y8J, N-((S)-3-methoxy-1-(((S)-3-methoxy-1-(((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)-2-methylthiazole-5-carboxamide, N-[(2S)-3-methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide, Oprozomib [USAN:INN], Onx0912(oprozomib), Oprozomib (USAN/INN), GTPL8739, SCHEMBL1709971, CHEMBL2103884, C25H32N4O7S, EX-A332, ONX0912, AOB87341, BCP07603, 2614AH, BDBM50398607, MFCD25976563, NSC766254, ZINC43202141, AKOS028109171, DB11991, NSC-766254, QC-9273, NCGC00345799-01, NCGC00345799-02, NCGC00345799-04, AS-17020, HY-12113, L-Serinamide, O-methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-, O-Methyl-N-((2-methylthiazol-5-yl)carbonyl)-L-seryl-O-methyl-N-((1S)-1-benzyl-2-((2R)- 2-methyloxiran-2-yl)-2-oxoethyl)-L-serinamide, A14181, D10318, J-690398, Q27088209, ONX 0912; PR 047; ONX-0912; PR-047; ONX0912; PR047, L-Serinamide, O-methyl-N-((2-methyl-5-thiazolyl)carbonyl)-L-seryl-O-methyl-N-((1S)-2- ((2R)-2-methyl-2-oxiranyl)-2-oxo-1-(phenylmethyl)ethyl)-, L-Serinamide, O-methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-2-oxiranyl]-2-oxo-1-(phenylmethyl)ethyl]-, N-((S)-3-methoxy-1-((S)-3-methoxy-1-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)-2-methylthiazole-5-carboxamide, N-?((S)?-?3-?methoxy-?1-?(((S)?-?3-?methoxy-?1-?(((S)?-?1-?((R)?-?2-?methyloxiran-?2-?yl)?-?1-?oxo-?3-?phenylpropan-?2-?yl)?amino)?-?1-?oxopropan-?2-?yl)?amino)?-?1-?oxopropan-?2-?yl)?-?2-?methylthiazole-?5-?carboxamide, PR-047|||ONX-0912|||N-[(2S)-3-Methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide

Pubchem:PUBCHEM:17753743

Id:bacacd07-5a95-54a8-b7ce-2634dd4c1fa0

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View oprozomib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for oprozomib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with oprozomib.

Results found

Linked to

	Label	Description
	oprozomib (651bf78d-fda2-4890-8249-caa2dd2fd6b7) Collection (Entity type)	Metadatata for oprozomib
	oprozomib negatively regulates SLC4A4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oprozomib positively regulates SLC7A11 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oprozomib positively regulates LGALS8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oprozomib negatively regulates NR2F1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Oprozomib bioactivity Proteasome subunit beta type-5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	oprozomib in similarity relationship with Thiostrepton Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid in similarity relationship with oprozomib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oprozomib positively regulates CXCL14 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oprozomib in similarity relationship with carfilzomib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS